Page 6 - Pharmaceutical Firms

Glenmark gets tentative nod from USFDA for generic psoriasis foam

Glenmark Pharmaceuticals on Monday said its US-based arm has received tentative approval from the US health regulator for its generic Calcipotriene and Betamethasone Dipropionate foam used to treat psoriasis. The tentative approval granted to Glenmark Pharmaceuticals Inc, USA (Glenmark) by the US Food & Drug Administration (USFDA) is for Calcipotriene and Betamethasone Dipropionate foam of strength 0.005 per cent/0.064 per cent, the company said in a statement. It is the generic equivalent of Leo Pharma AS' Enstilar foam, it added. Citing IQVIATM sales data for the 12 months ended March 2022, the company said Enstilar foam, 0.005 per cent/0.064 per cent achieved annual sales of approximately USD 115.2 million. Glenmark said its current portfolio consists of 174 products authorised for distribution in the US marketplace and 48 abbreviated new drug applications (ANDAs) are pending approval with the USFDA.

Venus Remedies dispatches first batch of essential medicines to Ukraine

The company has launched a social media campaign to motivate people in India and abroad to make voluntary contributions for the cause

CCI approves deal to acquire minority stake in BDR Pharmaceuticals

BDR Pharmaceuticals is mainly into four therapeutic segments -- oncology, critical care, gynaecology, and neurology

Mankind Pharma forays into agri-tech space, plans to invest Rs 200 crore

Mankind Pharma on Monday announced its foray into the agri-tech segment, with plans to invest up to Rs 200 crore in the first two to three years

Pharma SMEs stock up on a month's raw material amid supply disruptions

The lockdown in various Chinese provinces, including Shanghai, is likely to delay shipments by two weeks to a month, said domestic players.

Strong specialty sales and volumes keep it sunny for Sun Pharma

Rerating on the cards; the domestic business is expected to outperform

Exports up 25.1% to $34.57 bn in Feb; trade deficit widens to $20.88 bn

According to the data, gold imports in February dipped by 9.65 per cent to USD 4.8 billion

Piramal Pharma ropes in Ajay Devgn for skin-care brand Tetmosol

Piramal Pharma on Monday said its consumer products division has roped in Bollywood actor Ajay Devgn for its flagship brand Tetmosol.

Lupin signs Mary Kom as brand ambassador for its Shakti campaign

Homegrown pharma major Lupin Ltd on Monday said it has signed six-time world boxing champion and Olympics bronze medallist Mary Kom as brand ambassador for its Shakti campaign

Wockhardt sets issue price at Rs 225/share for Rs 748-cr rights issue

Earlier in January this year, Wockhardt's board had approved raising of up to Rs 1,000 crore through a rights issue to its existing shareholders

BDR Pharma introduces prostate cancer drug with enhanced strength

The company has introduced the medication, under the brand name BDENZA 160mg, at Rs 6,300 for a strip of seven tablets

Russia-Ukraine crisis: Indian pharma exporters in wait and watch mode

An official of Dr Reddy's Laboratories said they are closely monitoring the developments and ensuring the well-being of their staff in that region is the first and foremost priority

Zydus gets regulator nod to market generic diabetes drug in American

Zydus Group on Wednesday said it has received final approval from the US health regulator to market diabetes medication Dapagliflozin tablets in the American market. The drug maker has received final approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 5 mg and 10 mg. Dapagliflozin is used with a proper diet and exercise programme to control high blood sugar in people with type 2 diabetes. The drug also lowers the risk of heart failure in adults with type 2 diabetes with heart disease. It is also used to lower the risk of further worsening of kidney disease, end-stage kidney disease (ESKD), death due to cardiovascular disease, and hospitalisation for heart failure in adults with chronic kidney disease. Dapagliflozin works by increasing the removal of sugar by kidneys. The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad, Zydus Group stated. The group now has 328 approvals and has so far fi

Macleods Pharma files DRHP for second largest IPO by drug co at Rs 5,000 cr

It is entirely an offer for sale or OFS, company won't receive any of the proceeds

Ipca Laboratories' PAT declines 26% to Rs 199.9 crore in December quarter

The company had posted a consolidated net profit of Rs 265.47 crore in the corresponding period last fiscal, Ipca Laboratories said in a regulatory filing

Natco Pharma consolidated net profit up 27% to Rs 80 crore in Dec quarter

The Hyderabad-based company had reported a net profit of Rs 63.4 crore in the October-December period of previous fiscal

Serum backed Mylab to make and sell Covid-19 vax, working on 2-3 platforms

Partners with Shilpa Medicare to manufacture vaccines, therapeutics

Price erosion in US drags Alembic Pharma's Q3 net down 40% to Rs 176 cr

While the firm's US business fell 23% to Rs 393 cr in Q3FY22, its API sales were down 7% to Rs 198 crore

Pfizer to rake in earnings of over $100 bn in Covid vax & antiviral pill

On Tuesday, the company revealed its fourth quarter earnings and revenue projections for 2022 where it said it estimates it will earn up to $102 billion in sales next year, which would be a new record

GSK Pharma's net profit falls 3.9% to Rs 150.3 cr in December quarter

The company had posted a consolidated net profit of Rs 156.51 crore in the corresponding quarter last fiscal, GlaxoSmithKline Pharmaceuticals said in a regulatory filing